| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/23/2002 | US6376688 Malaria therapy |
| 04/23/2002 | US6376675 Pyridyl-1,2,5-thiadiazole derivatives |
| 04/23/2002 | US6376674 Bactericides; viricides |
| 04/23/2002 | US6376673 Central nervous system disorders |
| 04/23/2002 | US6376672 Restenosis; vision defects; cardiovascular disorders; kidney dieases |
| 04/23/2002 | US6376666 2-mercaptobenzimidazole derivatives possessing pharmacological activity |
| 04/23/2002 | US6376665 Antiarthritic agents, antiinflammatory agents |
| 04/23/2002 | US6376661 Human RNase H and compositions and uses thereof |
| 04/23/2002 | US6376657 Pharmaceutical compositions having appetite suppressant activity |
| 04/23/2002 | US6376557 Methods for treating alopecia |
| 04/23/2002 | US6376554 Method of treating sexual dysfunction |
| 04/23/2002 | US6376553 Treatment of pain |
| 04/23/2002 | US6376552 Treatment of gallstones |
| 04/23/2002 | US6376551 Treatment of chronic fatigue syndrome |
| 04/23/2002 | US6376550 Pharmaceutical compositions containing tramadol for migraine |
| 04/23/2002 | US6376549 Bioavailability; synergistic mixture |
| 04/23/2002 | US6376548 Enhanced propertied pesticides |
| 04/23/2002 | US6376547 N,n-substituted of glycine |
| 04/23/2002 | US6376545 Tablet |
| 04/23/2002 | US6376544 Nutritional product for a person having renal failure |
| 04/23/2002 | US6376543 After eye surgery |
| 04/23/2002 | US6376541 Topical administering |
| 04/23/2002 | US6376540 Furan nitrone compounds |
| 04/23/2002 | US6376539 Antiischemic agents, central nervous system disorders |
| 04/23/2002 | US6376538 Antiinflammatory agents; autoimmune diseases |
| 04/23/2002 | US6376537 Cancer treatment |
| 04/23/2002 | US6376536 Quaternary ammonium salts and their use |
| 04/23/2002 | US6376533 Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
| 04/23/2002 | US6376532 Neurotransmitter |
| 04/23/2002 | US6376531 Antidepressants |
| 04/23/2002 | US6376530 A n-methylaspartic acid antagonist; nervous system disorders, analgesics |
| 04/23/2002 | US6376529 Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof |
| 04/23/2002 | US6376526 For huans, animals |
| 04/23/2002 | US6376525 Method and composition for treating cancer using cellular organelle crystallizing agents |
| 04/23/2002 | US6376523 Hypotensive agents; antiinflammatory agents; endogenous vasoconstruction peptide |
| 04/23/2002 | US6376522 Microbiocides |
| 04/23/2002 | US6376519 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |
| 04/23/2002 | US6376518 Anticarcinogenic agents; side effect reduction |
| 04/23/2002 | US6376517 For treating vision loss, preventing vision degeneration, and promoting vision regeneration (?neopsis?) |
| 04/23/2002 | US6376515 Benzamides and related inhibitors of factor Xa |
| 04/23/2002 | US6376514 Piperidine-derived compounds containing a quinolyl group that inhibits p-glycoprotein transport protein activity; for treating cancer and other diseases |
| 04/23/2002 | US6376513 Drug for relieving pain and promoting the removal of calculi in urolithiasis |
| 04/23/2002 | US6376512 Therapeutic uses of quinoline derivatives |
| 04/23/2002 | US6376511 8-aminoquinolines |
| 04/23/2002 | US6376509 Melanocortin receptor agonists |
| 04/23/2002 | US6376508 Treatments for spinal muscular atrophy |
| 04/23/2002 | US6376507 NK-1 receptor antagonists for the treatment of neuronal injury and stroke |
| 04/23/2002 | US6376504 Phenethyl-5-bromopyridlythiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DBABO) derivatives exhibiting spermicidal activity |
| 04/23/2002 | US6376502 Osteoporosis compounds |
| 04/23/2002 | US6376501 Type 2 helper T cell-selective immune response suppressors |
| 04/23/2002 | US6376499 Piperazine-amide compound with anticoagulant activity |
| 04/23/2002 | US6376498 Pharmaceutical, cosmetic and/or food composition with antioxidant properties |
| 04/23/2002 | US6376497 Excellent, wide-spectrum antifungal activities and low toxicity |
| 04/23/2002 | US6376496 Inhibitors of prenyl-protein transferase |
| 04/23/2002 | US6376495 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them |
| 04/23/2002 | US6376493 Selective inhibition of phosphodiesterase iv and tumor necrosis factor; useful in treating osteoporosis, tumors, autoimmune diseases, rheumatic diseases, and asthma |
| 04/23/2002 | US6376492 Compounds and methods for inhibition of HIV and related viruses |
| 04/23/2002 | US6376491 Benzofuran derivatives for treatment or prevention of mycosis in mammals |
| 04/23/2002 | US6376490 Strong n-methyl-d-asparate receptor antagonists; useful in treating strokes, ischemia, and central nervous system injuries |
| 04/23/2002 | US6376489 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/23/2002 | US6376486 Methods of inhibiting sphincter incontinence |
| 04/23/2002 | US6376485 Benzoxazoles with PDE-inhibiting activity |
| 04/23/2002 | US6376482 Use of mesophase-stabilized compositions for delivery of cholesterol-reducing sterols and stanols in food products |
| 04/23/2002 | US6376481 Solid oral dosage form comprising support having given surface area range such as silicon dioxide, a stanol ester to reduce cholesterol, and a mixed micelle surfactant system |
| 04/23/2002 | US6376480 Vitamin D derivatives with substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents |
| 04/23/2002 | US6376478 N-acetylated (alpha)-linked acidic dipeptidase inhibitor; blocks release of glutamte pre-synaptically for reduced toxicity |
| 04/23/2002 | US6376477 Combination of an agent that binds to the androgen receptor and a bisphosphonic acid in the prevention and/or treatment of diseases involving calcium or phosphate metabolism |
| 04/23/2002 | US6376476 Isoprenoid pathway inhibitors for stimulating bone growth |
| 04/23/2002 | US6376475 Inhibiting biosynthesis of sialyl galactosides involved in immune responses; for treating graft rejection, autoimmune diseases, and allergies |
| 04/23/2002 | US6376472 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 04/23/2002 | US6376470 Cytosine arabinose, cytarabine, 1-(beta-d-arabinofuranosyl) cytosine nucleotide analog anticancer for acute myelogenous leukemia and some non-solid tumors; ara-c residues are only found on the termini of the polyethylene glycol polymer |
| 04/23/2002 | US6376468 Protein:prenyl transferase inhibitors |
| 04/23/2002 | US6376467 Peptide .epsilon.v1-2 is a particularly preferred inhibitory peptide. |
| 04/23/2002 | US6376242 Reduce the number of circulating platelets to low or below normal levels. |
| 04/23/2002 | US6376224 Composition comprising inhibitor for membrane pumps and photoaffinity-labeled chemotherapeutic agent |
| 04/23/2002 | US6376205 Contacting tau protein or derivative bound to solid phase with agent suspected of being modulator or inhibitor of tau-tau association and material which binds to said protein, detecting binding, wherein decrease indicates modulation |
| 04/23/2002 | US6376196 Contacting sample with isolated immunodominant neospora antigen, thereby forming antigen/antibody complex and detecting presence of antibodies specifically immunoreactive with bovine neospora antigen |
| 04/23/2002 | US6375989 Submucosa extracts |
| 04/23/2002 | US6375986 Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate |
| 04/23/2002 | US6375984 Aqueous-based pharmaceutical composition |
| 04/23/2002 | US6375979 Treating parkinson's disease, attention deficit hyperactivity disorder, dementia, depression, schizophrenia and dysautonomia; monoamine oxidase b inhibitor |
| 04/23/2002 | US6375978 Pre-annealing membrane polymer |
| 04/23/2002 | US6375976 Multi-purpose acid compositions |
| 04/23/2002 | US6375975 Pharmaceutical compositions for buccal and pulmonary application |
| 04/23/2002 | US6375973 Olopatadine and emedastine and an ophthalmically acceptable polymeric quaternary ammonium compound as a preservative |
| 04/23/2002 | US6375972 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 04/23/2002 | US6375962 React with alkylating agents such as mustard gas; may contain perfluoropolymers which are effective barrier compounds for pesticides, industrial solvents and chemical warfare agents |
| 04/23/2002 | US6375961 Cosmetic skin care compositions containing cumic alcohol |
| 04/23/2002 | US6375957 Drug abuse |
| 04/23/2002 | US6375952 Isolated herpes simplex virus polypeptide |
| 04/23/2002 | US6375950 Methods for inducing T cell unresponsiveness to donor tissue or organ in a recipient with gp39 antagonists |
| 04/23/2002 | US6375946 Antitumor, viricides,nk cell activating cytokine or a nk cell activating flavonoid and a compound effective to inhibit the production or release of hydrogen peroxide selected from the group consisting of histamine, other h.sub.2 receptor |
| 04/23/2002 | US6375929 Gene therapy for inhibition of angiogenesis |
| 04/23/2002 | US6375615 Tissue penetrating catheters having integral imaging transducers and their methods of use |
| 04/23/2002 | CA2268175C Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
| 04/23/2002 | CA2263353C Arylsulfonylimidazolone derivatives as an antitumor agent |
| 04/23/2002 | CA2252772C Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents |
| 04/23/2002 | CA2246727C Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 04/23/2002 | CA2229504C Flavanone-containing composition |
| 04/23/2002 | CA2223403C Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n-¬(aminoiminomethyl)phenylalkyl|-azaheterocyclylamide compounds |